ETF Watchlist: Week of July 3, 2017

Biotechs are fairly volatile on a short-term basis but still represent one of the better long-term growth plays. With a P/E ratio of 22, the Biotech ETF (IBB) isn’t unreasonably expensive and may yet have more room to run.